1.A prediction model for sarcopenia in postmenopausal women:information analysis based on the China Health and Retirement Longitudinal Study database
Guangzheng LI ; Wei LI ; Bochun ZHANG ; Haoqin DING ; Zhongqi ZHOU ; Gang LI ; Xuezhen LIANG
Chinese Journal of Tissue Engineering Research 2026;30(4):849-857
BACKGROUND:Sarcopenia is an age-related systemic skeletal muscle disease,which is associated with a variety of adverse outcomes such as falls,functional decline,frailty,and death.Postmenopausal women are one of the high-risk groups for sarcopenia.OBJECTIVE:To develop a predictive model for assessing the risk of sarcopenia in Chinese postmenopausal women based on high-quality database.METHODS:Data for this study were derived from 2 370 postmenopausal women from the China Health and Retirement Longitudinal Study(CHARLS),and sarcopenia was assessed using the Asian Working Group on Sarcopenia 2019(AWGS2019)recommended metrics.The study cohort was randomized into a training set(70%)and a validation set(30%).Risk factors for sarcopenia in postmenopausal women were screened using the least absolute shrinkage and selection operator,ten-fold cross-validation,and logistic regression.Nomogram predicting the risk of sarcopenia in postmenopausal women was constructed based on the risk factors,and the model efficacy was evaluated by the receiver operating characteristic curve and area under the curve(AUC),calibration curve,and decision curve analysis.RESULTS AND CONCLUSION:The prevalence of sarcopenia in this study was 23.50%and age,place of residence,sleep quality,cognitive function,depression,and the number of chronic diseases were selected as predictors of sarcopenia in postmenopausal women.The nomogram model showed good discrimination between the training and validation sets,with an AUC value of 0.751(95%confidence interval=0.724-0.778,P<0.001),a specificity of 72.2%,and a sensitivity of 63.2%in the training set,and an AUC value of 0.763(95%confidence interval=0.721-0.805,P<0.001),with a specificity of 69.6%and a sensitivity of 70.8%.The calibration curve showed a relatively significant agreement between the nomogram model and the actual observations,and the decision curve analysis demonstrated broad and good clinical utility.To conclude,the nomogram to assess the risk of sarcopenia constructed based on age,place of residence,sleep quality,cognitive function,depression,and number of chronic diseases,provides an effective tool for identifying and eliminating risk factors for sarcopenia in Chinese postmenopausal women,and helps to reduce the incidence of sarcopenia.
2.A prediction model for sarcopenia in postmenopausal women:information analysis based on the China Health and Retirement Longitudinal Study database
Guangzheng LI ; Wei LI ; Bochun ZHANG ; Haoqin DING ; Zhongqi ZHOU ; Gang LI ; Xuezhen LIANG
Chinese Journal of Tissue Engineering Research 2026;30(4):849-857
BACKGROUND:Sarcopenia is an age-related systemic skeletal muscle disease,which is associated with a variety of adverse outcomes such as falls,functional decline,frailty,and death.Postmenopausal women are one of the high-risk groups for sarcopenia.OBJECTIVE:To develop a predictive model for assessing the risk of sarcopenia in Chinese postmenopausal women based on high-quality database.METHODS:Data for this study were derived from 2 370 postmenopausal women from the China Health and Retirement Longitudinal Study(CHARLS),and sarcopenia was assessed using the Asian Working Group on Sarcopenia 2019(AWGS2019)recommended metrics.The study cohort was randomized into a training set(70%)and a validation set(30%).Risk factors for sarcopenia in postmenopausal women were screened using the least absolute shrinkage and selection operator,ten-fold cross-validation,and logistic regression.Nomogram predicting the risk of sarcopenia in postmenopausal women was constructed based on the risk factors,and the model efficacy was evaluated by the receiver operating characteristic curve and area under the curve(AUC),calibration curve,and decision curve analysis.RESULTS AND CONCLUSION:The prevalence of sarcopenia in this study was 23.50%and age,place of residence,sleep quality,cognitive function,depression,and the number of chronic diseases were selected as predictors of sarcopenia in postmenopausal women.The nomogram model showed good discrimination between the training and validation sets,with an AUC value of 0.751(95%confidence interval=0.724-0.778,P<0.001),a specificity of 72.2%,and a sensitivity of 63.2%in the training set,and an AUC value of 0.763(95%confidence interval=0.721-0.805,P<0.001),with a specificity of 69.6%and a sensitivity of 70.8%.The calibration curve showed a relatively significant agreement between the nomogram model and the actual observations,and the decision curve analysis demonstrated broad and good clinical utility.To conclude,the nomogram to assess the risk of sarcopenia constructed based on age,place of residence,sleep quality,cognitive function,depression,and number of chronic diseases,provides an effective tool for identifying and eliminating risk factors for sarcopenia in Chinese postmenopausal women,and helps to reduce the incidence of sarcopenia.
3.Mechanism of Feiyanning Formula in Suppressing Invasion and Metastasis of Lung Cancer Cells via Modulating Exosomal miR-328 and STAT3/c-Fos/NFATc1 Pathway
Junqing JI ; Chengcheng ZHANG ; Zhenye XU ; Zhongqi WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(17):144-154
ObjectiveTo investigate the molecular mechanism by which Feiyanning formula(FYN) regulated exosomal miR-328 to suppress the invasion and metastasis of lung cancer. MethodsIn vitro models using low-metastatic 95C and high-metastatic 95D lung cancer cell lines, along with isolated exosomes, were established. Initially, 95C and 95D cells were cultured, and exosomes were isolated from their supernatants. The exosomes were identified using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot. Exosome uptake assays confirmed that both 95C and 95D cells could internalize exosomes derived from lung cancer patients' plasma. Cell counting kit-8 (CCK-8) assays were performed to assess the inhibitory effects of FYN (0, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4 g·L-1) on 95C and 95D cell proliferation. Subsequent experiments were divided into three groups of control, low-dose FYN (1 g·L-1), and high-dose FYN (2 g·L-1) groups. Wound-healing and Transwell assays were used to evaluate the inhibitory effects of FYN on the migration and invasion of 95C and 95D cells. Western blot was employed to detect the protein expression levels of Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3), cellular oncogene Fos (c-Fos), and nuclear factor of activated T cells 1 (NFATc1). The mRNA expression of miR-328 was measured by Real-time quantitative polymerase chain reaction (Real-time PCR). ResultsLung cancer plasma-derived exosomes (EXO) enhanced the migration, invasion, and miR-328 expression levels in 95C and 95D cells (P<0.05, P<0.01). FYN inhibited the proliferation, invasion, and metastasis of 95C and 95D cells in a dose-dependent manner (P<0.01), with more pronounced effects on 95C cells. Additionally, FYN downregulated exosomal miR-328 expression and suppressed the protein levels of JAK2, STAT3, and its downstream target genes c-Fos and NFATc1 (P<0.01). ConclusionFYN may inhibit lung cancer metastasis by downregulating exosomal miR-328 expression, potentially through the STAT3/c-Fos/NFATc1 signaling pathway. Further studies are warranted to elucidate its detailed mechanisms and facilitate clinical application, providing insights into traditional Chinese medicine-based strategies for lung cancer treatment.
4.Mechanism of Traditional Chinese Medicine in Preventing and Treating Heart Failure Based on Macrophage Metabolism-Immune Regulatory Axis: A Review
Junlin ZHOU ; Xiaojiao ZHANG ; Jiahui CHEN ; Liyu LIN ; Shiyin ZHANG ; Yiyi CHEN ; Xiaoming DONG ; Wenjie LONG ; Huili LIAO ; Lu LU ; Zhongqi YANG ; Shihao NI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(23):269-282
Heart failure (HF) is the end-stage of various cardiovascular diseases, with high morbidity and mortality. The existing “new quadruple” standard treatment can hardly reverse the core pathological process of myocardial remodeling, and long-term medication may pose risks of drug resistance and adverse reactions. Therefore, new therapeutic targets and strategies are urgently needed. Metabolic reprogramming is the upstream core mechanism regulating phenotypic polarization and functional activation of macrophages, which drives the occurrence and development of HF through the core axis of metabolic reprogramming-immune imbalance-ventricular remodeling and has become a cutting-edge potential target for the prevention and treatment of HF. Traditional Chinese medicine (TCM) has a long history in the prevention and treatment of HF. A large number of studies in recent years have confirmed that different therapeutic methods of TCM can correct the polarization imbalance, restore the homeostasis of myocardial immune microenvironment, inhibit myocardial injury, and delay the pathological process of HF by targeting and regulating the metabolic reprogramming of glucose, lipids, mitochondria, and amino acids in macrophages. This paper systematically expounds the core pathological mechanism of metabolic reprogramming of macrophages in HF, sorts out the research progress of TCM in preventing and treating HF by intervening this target, analyzes the regulatory rules, summarizes the limitations of existing research, and puts forward future directions. This review aims to provide a systematic theoretical reference and new research ideas for TCM clinical diagnosis and treatment and new drug development of HF.
5.Clinical Observation on Tongyuan Acupuncture in the Treatment of Acute Gouty Arthritis
Lixian LI ; Minjie PAN ; Wenna ZHANG ; Qingxia XIE ; Zhongqi SHEN ; Jiaying XIAO ; Li CHEN
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(3):676-682
Objective To observe the clinical efficacy of Tongyuan acupuncture in the treatment of acute gouty arthritis.Methods A total of 126 cases of patients with definitive diagnosis of acute gouty arthritis admitted to the wards and outpatient clinics of Guangzhou Nansha District Hospital of Traditional Chinese Medicine from November 2023 to June 2024 were selected as the study subjects.The patients were randomly divided into observation group and control group according to the random number table method,with 63 cases in each group.The control group was given health training and conventional treatment,while the observation group was given Tongyuan acupuncture on the basis of treatment in the control group.Patients in both groups were treated for 14 consecutive days.After two weeks of treatment,the clinical efficacy of the two groups was evaluated.The changes in the clinical symptom scores,the Visual Analogue Scale(VAS)scores of pain,the levels of musculoskeletal ultrasonography(synovial proliferation,blood flow signals,and joint fluid)before and after the treatment were observed in patients of both groups.The changes of blood uric acid(UA),erythrocyte sedimentation rate(ESR),C-reactive protein(CRP),tumor necrosis factor α(TNF-α),and interleukin 1(IL-1)before and after treatment were compared between the two groups.Results(1)The total effective rate was 95.24%(60/63)in the observation group and 84.13%(53/63)in the control group.The efficacy of the observation group was superior to that of the control group,the difference being statistically significant(P<0.05).(2)After treatment,the clinical symptom scores and VAS scores of the patients in the two groups were improved significantly(P<0.05),and the improvement in the observation group was significantly superior to that in the control group,the difference being statistically significant(P<0.05).(3)After treatment,the serum UA,ESR,and CRP levels of patients in the two groups were improved significantly(P<0.05),and the improvement in the observation group was significantly superior to that in the control group,the difference being statistically significant(P<0.05).(4)After treatment,the TNF-α and IL-1 levels of patients in the two groups were improved significantly(P<0.05),and the improvement in the observation group was significantly superior to that in the control group,the difference being statistically significant(P<0.05).(5)After treatment,the musculoskeletal ultrasound indicators of the two groups of patients were improved significantly(P<0.05),and the improvement in the observation group was significantly superior to that in the control group,the difference being statistically significant(P<0.05).Conclusion Tongyuan acupuncture in the treatment of acute gouty arthritis can significantly improve the clinical symptoms of patients,reduce the level of patients'blood UA and inflammatory factor.
6.Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study.
Jingyi LI ; Yunsheng LIANG ; Wenli FENG ; Liehua DENG ; Hong FANG ; Chao JI ; Youkun LIN ; Furen ZHANG ; Rushan XIA ; Chunlei ZHANG ; Shuping GUO ; Mao LIN ; Yanling LI ; Shoumin ZHANG ; Xiaojing KANG ; Liuqing CHEN ; Zhiqiang SONG ; Xu YAO ; Chengxin LI ; Xiuping HAN ; Guoxiang GUO ; Qing GUO ; Xinsuo DUAN ; Jie LI ; Juan SU ; Shanshan LI ; Qing SUN ; Juan TAO ; Yangfeng DING ; Danqi DENG ; Fuqiu LI ; Haiyun SUO ; Shunquan WU ; Jingbo QIU ; Hongmei LUO ; Linfeng LI ; Ruoyu LI
Chinese Medical Journal 2025;138(16):2040-2042
7.Research progress on extrahepatic targeted delivery of mRNA-LNP
Lei LI ; Cai-li ZHAO ; Ning ZHANG ; Chun-lei LI
Acta Pharmaceutica Sinica 2025;60(2):359-368
Messenger ribonucleic acid (mRNA) is a promising therapeutic drug with great potential in the fields of immunology, oncology, vaccines and inborn metabolic diseases. However, due to its instability and susceptibility to nuclease degradation, efficient delivery vectors are required. Lipid nanoparticles (LNPs) are recognized as the most mature delivery vectors due to their advantages of easy formulation, high stability, efficient cell uptake and endosomal escape. However, the accumulation of LNPs in the liver severely limits the targeting and treatment of mRNA-LNP technology beyond the liver. To overcome this obstacle, researchers have been focusing on various means to achieve precise delivery of extrahepatic tissues and organs. This article mainly expounds the research progress of LNP-specific delivery mRNA from three aspects: endogenous targeting, active targeting and selection of administration route, in order to provide ideas and directions for the design of new mRNA-LNP delivery systems in the future.
8.Expression and prognostic significance of TM7SF2 in colorectal cancer based on bioinformatics analysis
Ying JIAN ; Zhongqi WANG ; Zhi ZHANG ; Xuemei ZHANG
China Modern Doctor 2025;63(5):9-12
Objective To analyze the expression and prognostic association of transmembrane 7 superfamily member 2(TM7SF2)in colorectal cancer using bioinformatics techniques.Methods The differential expression levels and clinical relevance of TM7SF2 mRNA in normal tissues and colorectal tumor tissues were analyzed using The Cancer Genome Atlas(TCGA)database.Evaluate the impact of TM7SF2 gene expression levels on patient prognosis through univariate and multivariate Cox regression analysis.Gene sets were download and score biological function changes by using the gene set variation analysis algorithm.Patients were divide into high and low expression groups based on TM7SF2 gene expression levels and the differences in signaling pathways with gene set enrichment analysis(GSEA)analyzed;use the CIBERSORT tool to assess the relationship between tumor immune cell infiltration and TM7SF2,apply the genomics of drug sensitivity in cancer(GDSC)database to predict the drug chemosensitivity of this gene,and describe the association between TM7SF2 gene expression and clinical indicators in colorectal cancer patients.Results Compared with normal tissues,the expression level of TM7SF2 in tumor tissues was significantly upregulated.Survival analysis indicates that high expression of the TM7SF2 gene was associated with poor prognosis in colorectal cancer patients.Through univariate and multivariate Cox regression model analysis,it was found that the expression level of TM7SF2 was a risk factor for the prognosis of colorectal cancer.Enrichment analysis suggested that TM7SF2 may play a role in pathways such as DNA replication,Wnt signaling pathway,and pentose phosphate pathway.TM7SF2 was positively correlated with regulatory T cells and CD8+T cells,and negatively correlated with memory CD4+T cells and neutrophils.In terms of drug sensitivity,TM7SF2 is correlated with the sensitivity to Camptothecin,Cisplatin,Docetaxel,Nilotinib,Olaparib,and Axitinib.Regression analysis showed that the contribution of TM7SF2 expression distribution to different clinical indicators varies.Conclusion TM7SF2 is highly expressed in colorectal cancer tissues and is associated with poor patient prognosis,can be used as a prognostic biomarker.
9.Research progress in the study of melatonin in the treatment of sepsis
Nan LI ; Wanchun TANG ; Zhongqi ZHANG ; Xiangrong ZUO
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(1):118-124
Sepsis poses a significant threat to hu-man health due to its widespread prevalence,high mortality rate,substantial treatment costs,and the absence of effective life-saving therapies.Melato-nin,a primary hormone regulating the circadian rhythm,has demonstrated potential as a promising therapeutic agent against sepsis.Its anti-inflamma-tory,antioxidant,immunomodulatory,mitochondri-al protective,and multi-organ protective effects are noteworthy.In this review,we summarize current research on the mechanisms of action and clinical efficacy of melatonin in sepsis treatment and multi-organ function preservation,aiming to offer new perspectives and support for sepsis research and therapy.
10.Research progress on the antitumor effects of immune checkpoint inhibitors
Qiang FU ; Zhongqi LU ; Ying CHANG ; Tiefeng JIN ; Meihua ZHANG
The Journal of Practical Medicine 2025;41(2):288-293
Tumor immunotherapy has emerged as a highly esteemed and rapidly evolving field in recent years,marked by the development of numerous significant therapeutic approaches. Among these,immune checkpoint inhibitors stand out as a pivotal strategy,attracting considerable attention due to their substantial research progress. This article provides a comprehensive review of the current research advancements in ten key immune checkpoints related to anti-tumor therapy,including PD-1/PD-L1,CTLA-4,LAG-3,TIM-3,TIGIT,and VISTA. By conducting an in-depth analysis of their mechanisms of action,clinical applications,and future research directions,this review aims to offer valuable insights and guidance for optimizing strategies in tumor immunotherapy.

Result Analysis
Print
Save
E-mail